Fact Checked

SurvivorNet Fact Checking and Medical Review Standards:  

The SurvivorNet News Team creates high quality medical information that complies with our industry leading standards for factual accuracy and sourcing from leading experts at academic medical institutions. Every news article is thoroughly fact-checked by our physician collaborators. We vet each piece of work for factual integrity, impartiality, and clearly label any professional conflicts.

All SurvivorNet articles adhere to the following standards:

  1. All studies and research papers cited are from reputable academic medical institutions or peer-reviewed journals.
  2. When we use data, statistics, or quotes these references link to the original source.
  3. All content related to new treatments, drugs, procedures, and so on must clearly describe availability, side effects, treatment target (such as triple negative breast cancer)
  4. All medical information on SurvivorNet is sourced from respected medical professionals with verified medical credentials and links are provided to these sources.
  5. We strive to give the reader relevant background information and include, clearly-sourced contextual health information in all articles. Readers are clearly alerted to any conflicts of interest from a medical source or the authors of a cited study.
/ Updated February 24th, 2023

How Do Biospecific Antibodies Work?

NOW
PLAYING
An Effective Chemotherapy Alternative to BCG Vaccine for Bladder Cancer
NOW
PLAYING
How Does Trodelvy Work For HER2-Negative, HR-Positive Metastatic Breast Cancer? Looking into the Newly Approved Option
NOW
PLAYING
BTK Inhibitor Jaypirca is Now FDA-Approved & May Help Difficult-to-Treat Mantle Cell Lymphoma
NOW
PLAYING
Exciting New Developments in Treatment For Mantle Cell Lymphoma
NOW
PLAYING
Bispecific Antibodies Show Promise For Follicular Lymphoma
NOW
PLAYING
Zanubrutinib May Delay Disease Progression in Chronic Lymphocytic Leukemia & Small Lymphocytic Lymphoma

Patient Pathfinder:

Clinical Trial Finder

Are you looking for other treatment options?
Right now there are ... non-hodgkin lymphoma trials in the U.S. within 100 miles of

Enter your zip code and travel distance to explore trials in your area...

Treatment : Understanding the Options for Diffuse Large B-Cell Lymphoma

SEE MORE   

Treatment : Understanding the Options for Diffuse Large B-Cell Lymphoma

  • The treatment you get for non-Hodgkin lymphoma will depend on the type of lymphoma, the stage and the how fast it’s growing
  • Diffuse large B-cell lymphoma is the most common type diagnosed in the United States and worldwide
  • People with aggressive non-Hodgkin lymphoma can expect to get a chemotherapy combination called R-CHOP

Treatment : Chemotherapy

SEE MORE   

Treatment : Treating Non-Hodgkin Lymphoma in Children

SEE MORE   

Treatment : Treating Non-Hodgkin Lymphoma in Children

  • Children with non-Hodgkin lymphoma are typically given more aggressive chemotherapy because their bodies are generally able to tolerate it better
  • Long-term survival in children with B-cell non-Hodgkin lymphoma is over 90%
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.